STUDY ON INCREASING THE EFFICIENCY IN VOLLEYBALL by Florin ȚURCANU, Dana Simona ȚURCANU

Subjects: “…volleyball, second line attack, quality…”
Get full text

STUDY ON INCREASING THE EFFICIENCY IN VOLLEYBALL by Florin ȚURCANU, Dana Simona ȚURCANU

Subjects: “…volleyball, second line attack, quality…”
Get full text

Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLC by Francesca Lucibello, MD, Valérie Gounant, MD, PhD, Mihaela Aldea, MD, PhD, Michaël Duruisseaux, MD, PhD, Maurice Perol, MD, Christos Chouaid, MD, Jaafar Bennouna, MD, PhD, Vincent Fallet, MD, Aldo Renault, MD, Florian Guisier, MD, PhD, Etienne Giroux-Leprieur, MD, PhD, Marie Wislez, MD, PhD, Anne-Claire Toffart, MD, PhD, Julien Mazieres, MD, PhD, Clémence Basse, MD, PhD, Nadia Hegarat, PhD, Matthieu Carton, MD, Nicolas Girard, MD, PhD

Subjects: Get full text

Clinical example of long-term control of disseminated signet-ring cell carcinoma of the stomach against the background of chemotherapy of the second line of treatment in combinatio... by T. A. Titova, N. S. Besova, E. V. Artamonova

Subjects: Get full text

Lurbinectedin in small cell lung cancer by Anna Manzo, Vincenzo Sforza, Guido Carillio, Giuliano Palumbo, Agnese Montanino, Claudia Sandomenico, Raffaele Costanzo, Giovanna Esposito, Francesca Laudato, Edoardo Mercadante, Carmine La Manna, Paolo Muto, Giuseppe Totaro, Rossella De Cecio, Carmine Picone, Maria Carmela Piccirillo, Giacomo Pascarella, Nicola Normanno, Nicola Normanno, Alessandro Morabito

Subjects: Get full text

Dolutegravir for second-line treatment: Programmatic implications of new evidence by Ying Zhao, Gary Maartens, Graeme Meintjes

Subjects: Get full text

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain? by Ingrid Garajová, Fabio Gelsomino, Massimiliano Salati, Anna Mingozzi, Marianna Peroni, Stefania De Lorenzo, Alessandro Granito, Francesco Tovoli, Francesco Leonardi

Subjects: Get full text

Second-Line Treatment Options for Hepatocellular Carcinoma: Current Landscape and Future Direction by Pathak S, Sonbol MB

Subjects: Get full text

Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II stud... by Yu Cheng, Zan Teng, Yanqiao Zhang, Bo Jin, Zhendong Zheng, Li Man, Zhenghua Wang, Yuee Teng, Ping Yu, Jing Shi, Ying Luo, Ying Wang, Jingdong Zhang, Huijuan Zhang, Jiwei Liu, Hao Chen, Jiawen Xiao, Lei Zhao, Lingyun Zhang, Yu Jiang, Ying Chen, Jian Zhang, Chang Wang, Sa Liu, Jinglei Qu, Xiujuan Qu, Yunpeng Liu

Subjects: Get full text

Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study by McNeil Ngongondo, Nora E. Rosenberg, Christopher C. Stanley, Robertino Lim, Dennis Ongubo, Richard Broadhurst, Colin Speight, Robert Flick, Petros Tembo, Mina C. Hosseinpour

Subjects: Get full text

Retention in care and virological failure among adult HIV+ patients on second-line ART in Rwanda: a national representative study by Sabin Nsanzimana, Muhammed Semakula, Vedaste Ndahindwa, Eric Remera, Dieudonne Sebuhoro, Jean Paul Uwizihiwe, Nathan Ford, Marcel Tanner, Steve Kanters, Edward J. Mills, Heiner C. Bucher

Subjects: Get full text

Successful conversion surgery for stage IV gastric cancer with liver metastases after second-line chemotherapy with ramucirumab and paclitaxel: a case report by Kosuke Fukuda, Takaaki Arigami, Koki Tokuda, Shigehiro Yanagita, Daisuke Matsushita, Yota Kawasaki, Satoshi Iino, Ken Sasaki, Akihiro Nakajo, Mari Kirishima, Akihide Tanimoto, Hitoshi Tsubouchi, Hiroshi Kurahara, Takao Ohtsuka

Subjects: Get full text

Survival predictors for second-line chemotherapy in Caucasian patients with metastatic gastric cancer by P Bohanes, P Morel, O Huber, DS Courvoisier, TV Perneger, AD Roth

Subjects: Get full text

Ramucirumab plus FOLFIRI or irinotecan as second-line treatment for patients with gastroesophageal adenocarcinoma: a review and meta-analysis of an emerging option by Haeseong Park, Samuel J. Klempner, Joseph Chao, Zev A. Wainberg, Mariusz Lukanowski, Suresh Chenji, Shannon Bourke, Anindya Chatterjee, Sylvie Lorenzen

Subjects: Get full text

Second-line Modified GTX versus Gemcitabine-Nab-Paclitaxel (GmAb) Following First-Line FOLFIRINOX in Advanced Pancreatic Cancer: A Retrospective Analysis at the American University... by Sally Temraz, Firas Kreidieh, Farah Nassar, Maria Mezher, Deborah Mukherji, Ali Shamseddine

Subjects: Get full text

Pediatric immune thrombocytopenia: a focus on eltrombopag as second-line therapy by Giuseppe Palumbo, Piero Farruggia, Ugo Ramenghi, Giovanna Russo, Alessandra Borchiellini, Marco Spinelli, Carlo Dufour, Fiorina Giona, Saverio Ladogana, Marco Zecca, Silverio Perrotta, Andrea Pession, Paola Giordano

Subjects: Get full text

A single-centre experience of febuxostat as a second-line urate-lowering therapy by Swee Gaik Ong, Hui Jen Ding

Subjects: Get full text

Comparison of Treatment Outcomes among Second-Line Antiretroviral Regimens in HIV/AIDS Patient by Winda Dwi Puspitasari, Nanang Munif Yasin, Fita Rahmawati

Subjects: Get full text

Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea by Shim JS, Kim Y, Yuh T, Lee JB, Kim HR, Hong MH, Cho BC, Lim SM

Subjects: Get full text

Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial by Thomas Zeyen, Anna-Laura Potthoff, Robert Nemeth, Dieter H. Heiland, Michael C. Burger, Joachim P. Steinbach, Peter Hau, Ghazaleh Tabatabai, Martin Glas, Uwe Schlegel, Oliver Grauer, Dietmar Krex, Oliver Schnell, Roland Goldbrunner, Michael Sabel, Niklas Thon, Daniel Delev, Hans Clusmann, Clemens Seidel, Erdem Güresir, Matthias Schmid, Patrick Schuss, Frank A. Giordano, Alexander Radbruch, Albert Becker, Johannes Weller, Christina Schaub, Hartmut Vatter, Judith Schilling, Frank Winkler, Ulrich Herrlinger, Matthias Schneider

Subjects: Get full text